NEW YORK (GenomeWeb News) – Spain's Institute of Molecular and Medical Genetics, or INGEMM, has purchased a CapitalBio Array Platform through the distributor Biotools, Biotools said today.

The Madrid-based INGEMM, located at the La Paz University Hospital, will also receive continuous training and advice from Biotools in the use of the platform and in the design of microarray experiments.

The company said the agreement is the beginning of "a close collaboration with INGEMM aimed at developing microarrays for pharmacogenomics and genetic disease diagnostics.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers have uncovered signals of selection that may enable the Bajau people to free five hundreds of feet deep, Reuters reports.

A new analysis examines the gender gap among paper authors in the sciences and says it may take decades or more to close.

In Science this week: paternally inherited cis-regulatory structural variants in autism, and more.

A new report outlines issues facing the implementation of personalized medicine in the UK, the Independent reports.

May
01
Sponsored by
Horizon Discovery

This webinar will provide an in-depth case study demonstrating how reference standards can be used to develop and validate circulating tumor DNA (ctDNA)-based assays.

May
08
Sponsored by
Dovetail Genomics

This webinar will discuss a proximity ligation-based method for studying structural variation in formalin-fixed paraffin-embedded (FFPE) tissue.